Scholars Central

Research articlePublished 2017

The Role of Novel 3d-Copper Cyanide Supramolecular Coordination Polymer in Epithelial Mesenchymal Transition Inhibition in Hepatocellular Carcinoma

Authors: Noura M Darwish, Fahad A Al-Dhabaan, Ahmed Sultan, Ahmed Malki, Mohamed Soliman Elshikh

Biochemistry & Pharmacology: Open Access

Volume 6 · Issue 3 · Pages 1–9

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Aberrant activation of the Ras/Raf-1/extracellular-regulated kinase (ERK) pathway has been shown to be involved in the progression of hepatocellular carcinoma (HCC). However, the mechanism of dysregulation of ERK activation is poorly understood. This study aimed to investigate the inhibitory effect of novel 3D-organocopper supramolecular coordination polymer (SCP) on invasive potential of hepatocellular carcinoma (HCC) cells and to explore the underlying mechanism. Chemoprevention could represent an important means to inhibit the process of hepatocarcinogenesis. Methods: The inhibitory effect of SCP compound on hepatoma cells was evaluated by the examination of HCC chemically induced liver tissues and specific pathway inhibition was examined by immunohistochemistry. Results: Recently, we identified the newly synthesized SCP as a potent inhibitor of the Ras/Raf-1/ERK pathway. In this study, we found that the expression levels of ERK1 and-2 in chemically induced HCC tissue was frequently decreased in response to SCP treatment, comparing with those untreated with SCP compound. Moreover, ERK expression levels in HCC tissue were frequently correlated with the incidence of tumor invasion and metastasis. Increased expression of beta catenin in liver tissue, which was associated with increased ERK activation. P-ERK1/2 overexpression also reduced the expression of E-cadherin, which play important roles in tumor invasion and metastasis. Conclusion: We concluded that SCP can effectively inhibit the invasive potential of ERK signaling pathway and ERK could be not only a novel prognostic factor but also a new therapeutic target for human HCC.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalBiochemistry & Pharmacology: Open Access
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Noura M Darwish”
  • BylineArticles whose byline prints “Fahad A Al-Dhabaan”
  • BylineArticles whose byline prints “Ahmed Sultan”
  • BylineArticles whose byline prints “Ahmed Malki”
  • BylineArticles whose byline prints “Mohamed Soliman Elshikh”